Literature DB >> 28282715

Personalized Regenerative Medicine.

Babak Arjmand1, Parisa Goodarzi2, Fereshteh Mohamadi-Jahani2, Khadijeh Falahzadeh1, Bagher Larijani3.   

Abstract

Personalized medicine as a novel field of medicine refers to the prescription of specific therapeutics procedure for an individual. This approach has established based on pharmacogenetic and pharmacogenomic information and data. The terms precision and personalized medicines are sometimes applied interchangeably. However, there has been a shift from "personalized medicine" towards "precision medicine". Although personalized medicine emerged from pharmacogenetics, nowadays it covers many fields of healthcare. Accordingly, regenerative medicine and cellular therapy as the new fields of medicine use cell-based products in order to develop personalized treatments. Different sources of stem cells including mesenchymal stem cells, embryonic stem cells and induced pluripotent stem cells (iPSCs) have been considered in targeted therapies which could give many advantages. iPSCs as the novel and individual pluripotent stem cells have been introduced as the appropriate candidates for personalized cell therapies. Cellular therapies can provide a personalized approach. Because of person-to-person and population differences in the result of stem cell therapy, individualized cellular therapy must be adjusted according to the patient specific profile, in order to achieve best therapeutic results and outcomes. Several factors should be considered to achieve personalized stem cells therapy such as, recipient factors, donor factors, and the overall body environment in which the stem cells could be active and functional. In addition to these factors, the source of stem cells must be carefully chosen based on functional and physical criteria that lead to optimal outcomes.

Entities:  

Keywords:  Induced pluripotent stem cells; Personalized medicine; Precision medicine; Regenerative medicine; Stem cell therapy

Mesh:

Year:  2017        PMID: 28282715

Source DB:  PubMed          Journal:  Acta Med Iran        ISSN: 0044-6025


  9 in total

Review 1.  How to establish infrastructures to achieve more efficient regenerative medicine?

Authors:  Babak Arjmand; Bagher Larijani; Sepideh Alavi-Moghadam; Hamid Reza Aghayan; Mostafa Rezaei-Tavirani; Parisa Goodarzi; Akram Tayanloo-Beik; Mahmood Biglar; Mohsen Rajaeinejad; Fatemeh Fazeli Shouroki
Journal:  Cell Tissue Bank       Date:  2022-07-24       Impact factor: 1.752

2.  The Outcome of Stem Cell-Based Therapies on the Immune Responses in Rheumatoid Arthritis.

Authors:  Peyvand Parhizkar Roudsari; Sepideh Alavi-Moghadam; Mostafa Rezaei-Tavirani; Parisa Goodarzi; Akram Tayanloo-Beik; Forough Azam Sayahpour; Bagher Larijani; Babak Arjmand
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Prospect of Stem Cell Therapy and Regenerative Medicine in Osteoporosis.

Authors:  Babak Arjmand; Masoumeh Sarvari; Sepideh Alavi-Moghadam; Moloud Payab; Parisa Goodarzi; Kambiz Gilany; Neda Mehrdad; Bagher Larijani
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-03       Impact factor: 5.555

Review 4.  Metabolomics and Cell Therapy in Diabetes Mellitus.

Authors:  Bagher Larijani; Parisa Goodarzi; Moloud Payab; Sepideh Alavi-Moghadam; Fakher Rahim; Nikoo Bana; Mina Abedi; Maryam Arabi; Hossein Adibi; Kambiz Gilany; Babak Arjmand
Journal:  Int J Mol Cell Med       Date:  2019-05-30

5.  High Efficiency Vibrational Technology (HEVT) for Cell Encapsulation in Polymeric Microcapsules.

Authors:  Silvia Pisani; Rossella Dorati; Ida Genta; Enrica Chiesa; Tiziana Modena; Bice Conti
Journal:  Pharmaceutics       Date:  2020-05-21       Impact factor: 6.321

Review 6.  Recent trends in stem cell-based therapies and applications of artificial intelligence in regenerative medicine.

Authors:  Sayali Mukherjee; Garima Yadav; Rajnish Kumar
Journal:  World J Stem Cells       Date:  2021-06-26       Impact factor: 5.326

Review 7.  Zebrafish for Personalized Regenerative Medicine; A More Predictive Humanized Model of Endocrine Disease.

Authors:  Babak Arjmand; Akram Tayanloo-Beik; Najmeh Foroughi Heravani; Setareh Alaei; Moloud Payab; Sepideh Alavi-Moghadam; Parisa Goodarzi; Mahdi Gholami; Bagher Larijani
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-17       Impact factor: 5.555

8.  Novel function of Nanos2 in expression of innate immunity genes and its probable roles in maintenance of pluripotency state.

Authors:  Monireh Bahrami; Maryam Moghaddam Matin; Moein Farshchian; Molood Asadi; Ahmad Reza Bahrami
Journal:  Iran J Basic Med Sci       Date:  2021-04       Impact factor: 2.699

Review 9.  Organ on a Chip: A Novel in vitro Biomimetic Strategy in Amyotrophic Lateral Sclerosis (ALS) Modeling.

Authors:  Babak Arjmand; Shayesteh Kokabi Hamidpour; Zahra Rabbani; Akram Tayanloo-Beik; Fakher Rahim; Hamid Reza Aghayan; Bagher Larijani
Journal:  Front Neurol       Date:  2022-01-17       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.